Soluble Urokinase Plasminogen Activator Receptor in Preoperatively Obtained Plasma from Patients with Gynecological Cancer or Benign Gynecological Diseases-Reference-Cited by-同舟云学术

Soluble Urokinase Plasminogen Activator Receptor in Preoperatively Obtained Plasma from Patients with Gynecological Cancer or Benign Gynecological Diseases

Published:2001-09 Issue:3 Volume:82 Page:523-531
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Riisbro R.,Stephens R.W.,Brünner N.,Christensen I.J.,Nielsen H.J.,Heilmann L.,von Tempelhoff G.-F.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference11 articles.

1. Cell-surface acceleration of urokinase-catalyzed receptor cleavage;Høyer-Hansen;Eur J Biochem,1997

2. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression;Wilhelm;J Cell Physiol,1999

3. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis;Stephens;J Natl Cancer Inst,1999

4. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients;Sier;Cancer Res,1998

5. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis;Slot;Ann Rheum Dis,1999

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients;Scientific Reports;2022-11-09

2. The role of soluble urokinase plasminogen activator receptor (suPAR) in patients with cancer: a review of the current literature;Medicinski Glasnik;2022-07-02

3. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation;Frontiers in Immunology;2021-12-02

4. Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?;Seminars in Thrombosis and Hemostasis;2021-08-27

5. Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis;BMJ Open;2020-07